Asthma Flashcards

1
Q

what immune cell mediates asthma?

A

CD4 mediated, and the lungs will show an eosinophil infiltrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the 3 main characteristics of asthma?

A

Airflow limitation
Airway hyper-responsiveness
Inflammation of the bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

in asthma, inflammation of the bronchi results in

A

infiltration by eosinophils, T cells and mast cells. Associated plasma exudate, oedema, smooth muscle hypertrophy, mucus plugging and epithelial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

asthma is

A

long term inflammation of the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the inflammatory process of asthma?

A

CD4 differentiates T helper cells
Excessive reaction by TH2 cells
Environmental triggers are picked up by dendritic cells and presented to TH2 cells
Produce cytokines like IL-5 and IL-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does IL-4 cause in asthma?

A

causes B cells to become plasma cells, which secrete IgE which coat mast cells (and basophils?) – produce histamines, leukotrienes, prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does IL-5 cause in asthma

A

produce eosinophils which promote immune response by producing more cytokines and leukotrienes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what type of hypersensitivity reaction is asthma?

A

Type 1 - IgE anitbodies produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the airway affects of the inflammation?

A

Minutes after allergen exposure:
Smooth muscle around bronchioles spams and increased mucous secretion
= narrows airways = difficult to breathe = obstructive
Also:
Increased vascular permeability and
Recruitment of immune cells - Eosinophils that release chemical mediators that physically damage endothelium of the lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the process behind irreversible damage in asthma?

A

Oedema, scarring and fibrosis build up
Thickens epithelial basement membrane
Permanently reduces airway diameter
Epithelial cells lose columnar cilated cells and these are replaced with over active mucous secreting cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the other intrinsic types of asthma?

A

non-atopic - recurrent viral resp infections
aspirin - increased leukotrienes and decreased prostaglandins
occupational - type 1 + 4, allergin can bind directly to T
food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 2 types of asthma?

A

Intrinsic and Extrinsic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is intrinsic asthma

A

asthma with no causatory factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when is the common onset of intrinsic asthma?

A

late onset - middle age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is extrinsic asthma

A

asthma with definite external causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the 2 types of extrinsic asthma?

A

atopic and non-atopic

17
Q

what are the causes of atopic asthma?

A

genetic - ADAM33, PHF11

environmental - hygiene hypothesis

18
Q

how is the ADAM33 gene linked to asthma?

A

airwar hyper-responsiveness and airway remodelling
is responsible for the release of factors by eosinophils. Some of these factors include MBP (major basic protein), ECP (eosinophil cationic protein) and other factors. These factors can cause remodelling of the epithelium, and stimulate growth of fibroblasts

19
Q

how is PHF11 linked with asthma?

A

increased IgE production

20
Q

what are common triggering symptoms of asthma?

A

Air Pollution – cigarettes, car exhausts
Allergens – dust, pet dander, cockroaches, mould
Medications – aspirin, beta blockers

21
Q

What are the common symptoms of asthma?

A

coughing, chest tightness, dyspnoea, wheezing, reduced air entry, sputum

22
Q

what are the features of wheeze in asthma?

A

Expiration
Audible
Polyphronic
Widespread

23
Q

what are the features of sputum in asthma?

A
curschman spiral (spiral shaped mucous plugs from small bronchi)
charcot-leyden crytsals – needle shaped, from breakdown of eosinophils
24
Q

what other aspects of an asthma history should you ask?

A

Precipitants, Diurnal variation, Exercise, Disturbed sleep, Acid reflux, Other atopic disease, The home, Job, Days per week of work or school

25
Q

what are the 2 main diagnostic features of asthma?

A

Diurnal variation of 20% on>3d a week for 2 weeks
↓ FEV1/FVC = <75%, obstructive pattern
(Usually >15% improvement in FEV1 following B2 agonists or steroid trial)

26
Q

Other diagnostic tests for asthma

A
PEFR monitoring
NO – raised in asthma 
Exercise Tests 
Trial of Corticosteroids 
Blood and Sputum tests 
CXR – hyperinflation
Skin prick tests may help identify allergens
Histamine or methacholine challenge 
Aspergillus serology
27
Q

what is the treatment of an asthma attack

A

Start on 100% O2 (non-rebreathing mask) with the patient sat upright in bed
Give 5mg salbutamol with 0.5mg ipratropium bromide via nebulizer on 100% O2
Give hydrocortisone 100mg IV or 50mg prednisolone orally. Give both if very unwell
Do CXR to exclude pneumothorax

28
Q

what is the management of a non resolved asthma attack

A

Inform ITU and seniors
Give magnesium sulphate 1.2-2g IV over 20 minutes
Change the nebulized salbutamol every 15 minutes, or give 10mg continuously per hour. Only give more ipratropium every 4-6 hours
Repeat PEF every 15-30 minutes to assess the situation

29
Q

Pharmacological management of asthma

A

Short acting β2agonists as required (unless using MART) – consider moving up if using three doses a week or more
Low-dose ICS
Add inhaled LABA to low-dose ICS (fixed dose or MART)
Increasing ICS to medium dose or Adding LTRA
If no response to LABA, consider stopping LABA
Refer to specialist care

30
Q

Step 1: Mild intermittent and exercise induced asthma is defined as

A

 Symptoms ≤2 times a week
 Asymptomatic and normal peak expiratory flow (PEF) between attacks
 Attacks are brief with varying intensity
 Night-time symptoms ≤2 times a month
 Forced expiratory flow at 1 second (FEV1) or PEF ≥80% of predicted
 PEF variability <20%.

31
Q

Step 2: mild persistent asthma is defined as

A
	Symptoms >2 times a week but <1 time a day
	Exacerbations may affect activity
	Night-time symptoms >2 times a month
	FEV1 ≥80% of predicted
	PEF variability between 20% and 30%.
32
Q

Step 3: moderate persistent asthma is defined as

A

 Daily symptoms
 Use of short-acting beta agonists daily
 Attacks affect activity
 Exacerbations ≥2 times a week and may last for days
 Night-time symptoms >1 time a week
 FEV1 greater than 60% to less than 80% of predicted
 PEF variability >30%.

33
Q

step 4-6 severe persistent asthma is defined as

A
	Continual symptoms
	Limited physical activity
	Frequent exacerbations
	Frequent night-time symptoms
	FEV1 ≤60% of predicted
	PEF variability >60%.
34
Q

what are the differential diagnosis of asthma?

A

pulmonary oedema, COPD, large airway obstruction, SVC obstruction, pneumothorax, PE, bronchiectasis, obliterative bronchiolitis

35
Q

what are the “bonus points” treatment for asthma attack?

A
ensure good analgesia
take time to reassure patient 
check inhaler technique
PEFR
check compliance
36
Q

which type of respiratory failure is common in asthma attacks?

A

type 2 respiratory failure (low CO2, high O2)

37
Q

Treatment of Life threatening asthma

A
recognise
call for help
high flow o2
back to back inhalers
IV hydrocortisone
IV magnesium
IV aminophylline infusion
ECG